AIRO vs REGN · rev $6.3M vs P/E 14, rev $14.34B
AIRO Group Holdings, Inc (AIRO) versus Regeneron Pharmaceuticals Inc (REGN) — a side-by-side from cached financials, not a winner call.
AIRO Group Holdings, Inc (AIRO) is a aerospace & defense company listed on US.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Latest reported AIRO revenue for 2025-09-30 was $6.3M. Net income was -$8.0M. Revenue was down 74.4% from 2025-06-30 to 2025-09-30. AIRO currently screens at market cap $775.4M.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
AIRO currently screens at market cap $775.4M. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Not investment advice. Open the AIRO and REGN stock pages for the full models.
Not investment advice.